Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
CAMBRIDGE, Mass., Sept. 24, 2024 ( GLOBE NEWSWIRE ) -- Wave Life Sciences Ltd. ( Nasdaq: WVE ) , a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, announced today that it has commenced an underwritten public offering of ...
| Ticker |
Sentiment |
Impact |
|
BR
|
Neutral
|
5 %
|
|
STT
|
Neutral
|
5 %
|
|
WVE
|
Somewhat Bullish
|
23 %
|
